Chitosan oligosaccharides attenuate ocular inflammation in rats with experimental autoimmune anterior uveitis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Fang, I Mo ^a   Yang, Chang Hao ^b   Yang, Chung May ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN DERIVATIVE; CHITOSAN OLIGOSACCHARIDE; FRACTALKINE; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MELANIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OCULAR ANTIINFLAMMATORY AGENT; RANTES; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHITOSAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGOSACCHARIDE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE ANTERIOR UVEITIS; EXPERIMENTAL AUTOIMMUNE DISEASE; EXPERIMENTAL UVEITIS; EYE INFLAMMATION; FOOT PAD; IMMUNOFLUORESCENCE; IN VITRO STUDY; IRIDOCYCLITIS; LEWIS RAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; EYE; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; AQUEOUS HUMOR; CHITOSAN; DISEASE MODELS, ANIMAL; EYE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; OLIGOSACCHARIDES; RATS; UVEITIS, ANTERIOR;

EID: 84928639468     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/827847     Document Type: Article

References (43)

1. R. B. Nussenblatt and S. M. Whitcup, Uveitis: Fundamentals and Clinical Practice, Mosby/Elsevier Science, Philadelphia, Pa, USA, 3rd edition, 2004.
2. D. A. Jabs, J. T. Rosenbaum, C. S. Foster et al. , "Guidelines for the use of immunosuppressive drugs in patientswith ocular inflammatory disorders: recommendations of an expert panel, " The American Journal of Ophthalmology, vol. 130, no. 4, pp. 492-513, 2000.
3. M. C. Kim, N. H. Kabeer, M. T. Tandhasetti, H. J. Kaplan, and N. S. Bora, "Immunohistochemical studies on melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU), " Current Eye Research, vol. 14, no. 8, pp. 703-710, 1995.
4. R. M. Broekhuyse, E. D. Kuhlmann, H. J. Winkens, and A. H. M. van Vugt, "Experimental autoimmune anterior uveitis (EAAU), a new formof experimental uveitis. I: induction by a detergentinsoluble, intrinsic protein fraction of the retinal pigment epithelium, " Experimental Eye Research, vol. 52, no. 4, pp. 465-474, 1991.
5. R. M. Broekhuyse, E. D. Kuhlmann, and H. J. Winkens, "Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium, " Experimental Eye Research, vol. 55, no. 3, pp. 401-411, 1992.
6. R. M. Broekhuyse, H. J. Winkens, and E. D. Kuhlmann, "Intraperitoneally injected melanin is highly uveitogenic, " Experimental Eye Research, vol. 62, no. 2, pp. 199-200, 1996.
7. N. S. Bora, M. C. Kim, N. H. Kabeer et al. , "Experimental autoimmune anterior uveitis: induction with melanin-associated antigen from the iris and ciliary body, " Investigative Ophthalmology and Visual Science, vol. 36, no. 6, pp. 1056-1066, 1995.
8. C.-C. Chan, N. Hikita, K. Dastgheib, S. M. Whitcup, I. Gery, and R. B. Nussenblatt, "Experimental melanin-protein-induced uveitis in the Lewis rat: immunopathologic processes, " Ophthalmology, vol. 101, no. 7, pp. 1275-1280, 1994.
9. H.-O. Pae, W.-G. Seo, N.-Y. Kim et al. , "Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer, " Leukemia Research, vol. 25, no. 4, pp. 339-346, 2001.
10. R. Pangestuti and S. K. Kim, "Neuroprotective properties of chitosan and its derivatives, "MarineDrugs, vol. 8, no. 7, pp. 2117-2128, 2010.
11. C. Qin, Y. Du, L. Xiao, Z. Li, and X. Gao, "Enzymic preparation of water-soluble chitosan and their antitumor activity, " International Journal of BiologicalMacromolecules, vol. 31, pp. 1111-1117, 2002.
12. Q. Chen, S. Liu, Y. Du, H. Peng, and L. Sun, "Carboxymethylchitosan protects rabbit chondrocytes from interleukin-1β-induced apoptosis, " European Journal of Pharmacology, vol. 541, no. 1-2, pp. 1-8, 2006.
13. G. Joodi, N. Ansari, and F. Khodagholi, "Chitooligosaccharidemediated neuroprotection is associated with modulation of Hsps expression and reduction of MAPK phosphorylation, " International Journal of Biological Macromolecules, vol. 48, no. 5, pp. 726-735, 2011.
14. I. M. Fang, C. H. Yang, C. M. Yang, and M. S. Chen, "Chitosan oligosaccharides attenuates oxidative-stress related retinal degeneration in rats, " PLoS ONE, vol. 8, no. 10, p. e77323, 2013.
15. M. Tanito, A. Nishiyama, T. Tanaka et al. , "Change of redox status and modulation by thiol replenishment in retinal photooxidative damage, " Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2392-2400, 2002.
16. B. Manickam, P. Jha, B. Matta, J. Liu, P. S. Bora, and N. S. Bora, "Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses, " The Journal of Biological Chemistry, vol. 286, no. 10, pp. 8472-8480, 2011.
17. J. A. Hedrick and A. Zlotnik, "Chemokines and lymphocyte biology, " Current Opinion in Immunology, vol. 8, no. 3, pp. 343-347, 1996.
18. G. Adamus, M. Manczak, and M. Machnicki, "Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE, " Investigative Ophthalmology and Visual Science, vol. 42, no. 12, pp. 2894-2903, 2001.
19. I. J. Crane, S. McKillop-Smith, C. A. Wallace, G. R. Lamont, and J. V. Forrester, "Expression of the chemokines MIP-1α, MCP-1, and RANTES in experimental autoimmune uveitis, " Investigative Ophthalmology and Visual Science, vol. 42, no. 7, pp. 1547-1552, 2001.
20. H. B. Juel, C. Faber, M. S. Udsen, L. Folkersen, and M. H. Nissen, "Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activatedTcells, " Investigative Ophthalmology and Visual Science, vol. 53, no. 13, pp. 8472-8480, 2012.
21. J. R. Smith, P. H. Hart, and K. A. Williams, "Basic pathogenic mechanisms operating in experimentalmodels of acute anterior uveitis, " Immunology andCell Biology, vol. 76, no. 6, pp. 497-512, 1998.
22. I. Fang, C. Yang, C. Lin, C. Yang, and M. Chen, "Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis, " Experimental Eye Research, vol. 78, no. 6, pp. 1043-1055, 2004.
23. C. H. Yang, I.-M. Fang, C. P. Lin, and M. S. Cben, "Effects of the NF-αB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis, " Investigative Ophthalmology and Visual Science, vol. 46, no. 4, pp. 1339-1347, 2005.
24. I. M. Fang, C. P. Lin, C. M. Yang, and M. Chen, "Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis, " Molecular Vision, vol. 11, pp. 443-451, 2005.
25. N. S. Bora, M. D. Woon, M. T. Tandhasetti, T. P. Cirrito, and H. J. Kaplan, "Induction of experimental autoimmune anterior uveitis by a self-antigen: Melanin complex without adjuvant, " Investigative Ophthalmology and Visual Science, vol. 38, no. 10, pp. 2171-2175, 1997.
26. P. P. Tak and G. S. Firestein, "NF-αB: a key role in inflammatory diseases, " Journal of Clinical Investigation, vol. 107, no. 1, pp. 7-11, 2001.
27. F. Chen, V. Castranova, X. Shi, and L. M. Demers, "Newinsights into the role of nuclear factor-αB, a ubiquitous transcription factor in the initiation of diseases, " Clinical Chemistry, vol. 45, no. 1, pp. 7-17, 1999.
28. H. Moriuchi, M. Moriuchi, and A. S. Fauci, "Nuclear factor-αB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection, " The Journal of Immunology, vol. 158, no. 7, pp. 3483-3491, 1997.
29. R. R. Freter, J. A. Alberta, G. Y. Hwang, A. L. Wrentmore, and C. D. Stiles, "Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-αB and a 90-kDa phosphoprotein coactivator, " The Journal of Biological Chemistry, vol. 271, no. 29, pp. 17417-17424, 1996.
30. S. Lemay, T. V. Lebedeva, and A. K. Singh, "Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-αB-independent mechanism, " Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 4, pp. 567-572, 1999.
31. E. Jacquemin, Y. De Kozak, B. Thillaye, Y. Courtois, and O. Goureau, "Expression of inducible nitric oxide synthase in the eye fromendotoxin-induced uveitis rats, " Investigative Ophthalmology and Visual Science, vol. 37, no. 6, pp. 1187-1196, 1996.
32. R. Pangestuti, S. Bak, and S. Kim, "Attenuation of proinflammatory mediators in LPS-stimulated BV2 microglia by chitooligosaccharides via the MAPK signaling pathway, " International Journal of Biological Macromolecules, vol. 49, no. 4, pp. 599-606, 2011.
33. H. J. Yoon, M. E. Moon, H. S. Park, S. Y. Im, and Y. H. Kim, "Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264. 7 macrophage cells, " Biochemical and Biophysical Research Communications, vol. 358, no. 3, pp. 954-959, 2007.
34. Y. Qiao, X. Bai, and Y. Du, "Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress, " International Immunopharmacology, vol. 11, no. 1, pp. 121-127, 2011.
35. J. C. Fernandes, H. Spindola, V. de Sousa et al. , "Anti-inflammatory activity of chitooligosaccharides in vivo, " Marine Drugs, vol. 8, no. 6, pp. 1763-1768, 2010.
36. M. Yousef, R. Pichyangkura, S. Soodvilai, V. Chatsudthipong, and C. Muanprasat, "Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action, " Pharmacological Research, vol. 66, no. 1, pp. 66-79, 2012.
37. P. Wei, P. Ma, Q. Xu et al. , "Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro, " Glycoconjugate Journal, vol. 29, no. 5-6, pp. 285-295, 2012.
38. T. M. Carlos and J. M. Harlan, "Leukocyte-endothelial adhesion molecules, " Blood, vol. 84, no. 7, pp. 2068-2101, 1994.
39. A. Hafezi-Moghadam, K. Noda, L. Almulki et al. , "VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation, " FASEB Journal, vol. 21, no. 2, pp. 464-474, 2007.
40. S. M. Whitcup, N. Hikita, M. Shirao et al. , "Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis, " Experimental Eye Research, vol. 60, no. 6, pp. 597-601, 1995.
41. X. Yang, H. Jin, K. Liu, Q. Gu, and X. Xu, "A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-αB signaling pathway, " PLoS ONE, vol. 6, no. 12, Article ID e29155, 2011.
42. B. Manickam, P. Jha, N. J. Hepburn et al. , "Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU), " Molecular Immunology, vol. 48, no. 1-3, pp. 231-239, 2010.
43. Y. Li, Q. Xu, P. Wei et al. , "Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling, " International Journal of Molecular Medicine, vol. 33, pp. 392-400, 2014.